Skip to Content
Merck
  • Effect of short-chain fatty acids on Epstein-Barr virus early and viral capsid antigen induction in P3HR-1 cells.

Effect of short-chain fatty acids on Epstein-Barr virus early and viral capsid antigen induction in P3HR-1 cells.

Cancer letters (1980-12-01)
M Kawanishi, Y Ito
ABSTRACT

The effects of short-chain fatty acids were assayed for their capacity to induce Epstein-Barr virus (EBV) from the EBV genome-carrying human lymphoblastoid P3HR-1 cells. Not only the n-butyric acid, the activity of which is now well established, but also the n-valeric acid was found to induce EBV-associated early antigen (EA) and viral capsid antigen (VCA) at an appreciable level. Similarly, i-valeric acid showed a considerably lower, but significant, level of this activity, while the i-butyric acid was inactive. All other fatty acids with either a chain shorter than butyric or longer than valeric showed only a marginal effect or none at all. Thus, the decisive factor for EBV-inducing capacity of the fatty acids concerns adequate length and configuration of the basic structure of the molecules.

MATERIALS
Product Number
Brand
Product Description

Supelco
Butyric acid, analytical standard
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Butyric acid, ≥99%, FG
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Butyric acid, SAJ special grade, ≥99.5%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Butyric acid, natural, ≥99%, FCC, FG
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Butyric acid, ≥99%
SKU
Pack Size
Availability
Price
Quantity